1. Home
  2. Stock quotes
  3. Reata Pharmaceuticals
  4. Financial Ratios
Reata Pharmaceuticals logo
Reata Pharmaceuticals RETA
$ 172.36 0.0%
mail-toReport an Error

Quarterly report 2023-Q1
added 05-10-2023

report update icon

Reata Pharmaceuticals Financial Ratios 2011-2024 | RETA

Annual Financial Ratios Reata Pharmaceuticals

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

 -5.3 -3.4 -14.1 -20.3 -26.5 -14.5 -79.5 - - - - -

P/S

 741.9 88.9 387.2 222.6 39.8 14.4 9.9 - - - - -

EPS

 -8.5 -8.2 -7.3 -9.5 -2.9 -2.0 -0.3 -0.1 0.0 - - -

EV (Enterprise Value)

 1.6 B 431 M 2.67 B 5.66 B 2.13 B 846 M 715 M 310 M 312 M 507 M - -

EBITDA per Share

 0.03 0.03 0.03 -9.35 -2.76 -1.94 -0.313 - - - - -

EV/EBITDA

 354.7 -13.0 -19.0 -24.5 -12.6 -66.2 - - - - -

PEG

 -0.03 -1.04 0.09 0.57 0.03 4.56 - - - - -

P/B

 3.2 1.4 4.1 23.0 140.7 -4.7 -2.3 - - - - -

P/CF

 -8.0 -4.3 -10.8 -23.3 -25.3 -8.3 -25.3 - - - - -

ROE %

 474.77 -159.89 -59.35 -112.97 -531.34 32.44 2.90 - - - - -

ROA %

 -60.62 -40.46 -28.89 -42.52 -23.33 -35.22 -6.99 - - - - -

ROCE %

 - - - -58.16 -26.57 -53.48 -23.36 - - - - -

Current Ratio

 - - - 3.5 6.1 2.8 1.5 - - - - -

DSO

 - - - - - - - - - - - -

DIO

 - - - - - - - - - - - -

DPO

 - - - 5.6 - - - - - - - -

Operating Cycle

 - - - - - - - - - - - -

Cash Conversion Cycle

 - - - -5.6 - - - - - - - -

All numbers in USD currency

Quarterly Financial Ratios Reata Pharmaceuticals

2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

 -3.14 - -2.16 -2.02 -2.03 - -1.97 -2 -1.86 -1.9 -1.94 -2.03 -1.47 -5.91 -1.32 -1.14 -0.98 -0.86 -1.07 -1.08 0.16 -0.64 -0.5 -0.52 -0.32 -0.19 -0.04 -0.05 -0.02 -0.11 0.04 -0.11 0.08 - - - - - - - - - - - - - - - -

EBITDA per Share

 0.01 - 0.01 0.01 0.01 - 0.01 0.01 0.01 - 0.01 0.01 0.01 - 0.01 0.01 0.01 - - - - - - - 0.01 - 0.01 0.01 0.01 - 0.03 0.03 - - - - - - - - - - - - - - - - -

ROE %

 -3517.07 -1914.33 -1942.40 -221.09 -137.09 -69.50 -85.25 -72.87 -65.89 -59.35 -116.37 -116.15 -113.34 -112.97 -208.95 -396.90 -569.62 -531.34 -351.24 -139.45 54.53 32.44 23.01 15.06 7.61 2.90 1.61 0.96 1.15 1.03 0.39 0.62 - - - - - - - - - - - - - - - - -

ROA %

 -64.32 -36.04 -45.86 -42.14 -39.84 -27.44 -35.11 -32.93 -31.46 -28.89 -48.61 -46.80 -43.96 -42.52 -22.54 -25.65 -28.79 -23.33 -28.24 -28.40 -28.80 -35.22 -27.55 -19.46 -11.94 -6.99 -4.56 -2.75 -3.85 -3.56 -1.35 -2.15 - - - - - - - - - - - - - - - - -

ROCE %

 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Current Ratio

 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DSO

 - - - - - - - - - - - - - - - - - - 268.5 342.1 38.5 4.6 - 3.6 3.6 - - - - - - - - - - - - - - - - - - - - - - - -

DIO

 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DPO

 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Cycle

 - - - - - - - - - - - - - - - - - - 268.5 342.1 38.5 4.6 - 3.6 3.6 - - - - - - - - - - - - - - - - - - - - - - - -

Cash Conversion Cycle

 - - - - - - - - - - - - - - - - - - 268.5 342.1 38.5 4.6 - 3.6 3.6 - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency